Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.WT

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Questions relating to Warrants
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(577)
•••
Comment by Quattro74on Aug 01, 2020 10:36pm
272 Views
Post# 31354764

RE:RE:RE:RE:RE:RE:RE:Questions relating to Warrants

RE:RE:RE:RE:RE:RE:RE:Questions relating to Warrants
BlueFranky wrote: thanks

Surely we wouldn't go cheap....that said, these days, there are no doubt many shareholders who would just as soon take a reasonable offer rather than wait to be filthy rich down the road....so I ask, what might be a reasonable offer. What would an offer based on one billion look like...as in, at what multiple- what would be a reasonable pps for a take out given really good date yr. end?



$1B US is equal to ~ $3.60 a share US. I'm with ya blue, cheap buyout very soon I'm ok with, as long as this is gonna drag out I would hope for much better.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities